Nuvalent NUVL
NUVL
$123.96 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Nuvalent (NUVL) Change in Acquisitions & Divestments (2022 - 2026)

Nuvalent's (NUVL) quarterly Change in Acquisitions & Divestments came in at $181.5 million in Q1 2026, down 40.0% YoY from $302.6 million in Q1 2025, and up 11.31% on a QoQ basis from $163.1 million in Q4 2025.

Analysis

Nuvalent (NUVL) Change in Acquisitions & Divestments (2022 - 2026) Analysis & Trends

Nuvalent (NUVL) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $181.5 million in Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 40.0% year-over-year to $181.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $812.6 million (up 19.9% YoY) and the FY2025 annual result came in at $933.7 million, up 106.82% from the prior year.
  • Change in Acquisitions & Divestments grew to $181.5 million in Q1 2026, from $163.1 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $302.6 million in Q1 2025 to a low of $27.0 million in Q1 2022.
  • A 5-year average of $122.6 million and a median of $105.0 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
  • Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments soared 296.85% — and 2026, when it slumped 40.0%.
  • Tracing NUVL's Change in Acquisitions & Divestments over 5 years: stood at $97.2 million in 2022, then climbed by 13.62% to $110.5 million in 2023, then increased by 28.96% to $142.4 million in 2024, then increased by 14.5% to $163.1 million in 2025, then rose by 11.31% to $181.5 million in 2026.
  • The last three Change in Acquisitions & Divestments figures came in at $181.5 million (Q1 2026), $163.1 million (Q4 2025), and $232.4 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Nuvalent 9.75 Bn 9.75 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 181.55 Mn
Dec 31, 2025 163.10 Mn
Sep 30, 2025 232.44 Mn
Jun 30, 2025 235.55 Mn
Mar 31, 2025 302.59 Mn
Dec 31, 2024 142.45 Mn
Sep 30, 2024 127.71 Mn
Jun 30, 2024 105.04 Mn
Mar 31, 2024 76.25 Mn
Dec 31, 2023 110.46 Mn
Sep 30, 2023 61.61 Mn
Jun 30, 2023 83.21 Mn
Mar 31, 2023 60.69 Mn
Dec 31, 2022 97.22 Mn
Sep 30, 2022 37.13 Mn
Jun 30, 2022 40.90 Mn
Mar 31, 2022 27.00 Mn